Strides Shasun posts Q4 FY17 and H2 FY 17 results

The company achieved 95 per cent of the guidance with H2 FY 17 EBITDA at Rs 4,200 million despite a challenging operating environment

Strides Shasun has announced its Q4 FY17 and H2 FY 17 results. In H2 FY 17, the company registered an EBITDA of Rs 4,400 – 4,750 million. The company achieved 95 per cent of the guidance with H2 FY 17 EBITDA at Rs 4,200 million despite a challenging operating environment.

In Q4 FY 17, the company registered total revenues of Rs 9,231 million against Rs 9,163 million in Q4 FY16, showing a growth of one per cent Y-o-Y. In H2 FY 17, total revenues were at Rs 35,106 million against Rs 28,499 million in FY16, registering a growth of 23 per cent Y-o-Y. EBITDA for Q4 FY 17 was at Rs 2,133 million up 15 per cent Y-o-Y, showing a growth of 23 per cent Y-o-Y. EBITDA for H2 FY 17 was at Rs 7,191 million up 38 per cent Y-o-Y, EBITDA margins was at 20 per cent up 220 bps Y-o-Y.

Shashank Sinha, Group CEO, Strides Shasun stated, “We delivered a solid quarter. Key products continue to gain market share driving growth in the base business. New product filing momentum picked up as we nearly doubled R&D investments. Our last four consecutive US FDA audits have been successful with zero 483’s. A strong pipeline, compliant manufacturing base and growing market presence are the pillars of our future growth.”